Mykare closes $3.2M bridge round to grow hospital network and AI tools
What's the deal? Indian healthtech startup Mykare HealthDealroom has a profile for this one. Try Dealroom → has closed a bridge round at $3.2 million (₹30.2 Cr), with backing from Papa cofounders Andrew ParkerDealroom has a profile for this one. Try Dealroom → and Alfredo VaamondeDealroom has a profile for this one. Try Dealroom →, alongside a Middle Eastern family office.
The latest tranche added $1 million (₹9.4 Cr) to the previously undisclosed round.
Founded in 2022, Mykare connects patients with a network of hospitals offering more affordable care than large branded chains.
Why now? The startup plans to use the funds to boost its AI capabilities, speed up product development, and push deeper into existing international markets.
It is building an AI-native healthcare operating system that lets clinics and hospitals automate the entire patient journey — from voice AI and appointment booking to feedback and retention.
The signal: MykareDealroom has a profile for this one. Try Dealroom →, classified by Dealroom as a breakout-stage company, is betting that an AI-native operating system can scale its affordable surgical care network for India's middle class. The backing from US healthtech veterans and a Middle Eastern family office points to rising cross-border interest in India's lower-cost care models.
Read more: Inc42
Image credit: Generated with Gemini
